Identifying Genes for Establishing a Multigenic Test for Hepatocellular Carcinoma Surveillance in Hepatitis C Virus-Positive Cirrhotic Patients
- 1 November 2009
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 18 (11), 2929-2932
- https://doi.org/10.1158/1055-9965.epi-09-0767
Abstract
In this study, we used the Affymetrix HG-U133A version 2.0 GeneChips to identify genes capable of distinguishing cirrhotic liver tissues with and without hepatocellular carcinoma by modeling the high-dimensional dataset using an L1 penalized logistic regression model, with error estimated using N-fold cross-validation. Genes identified by gene expression microarray included those that have important links to cancer development and progression, including VAMP2, DPP4, CALR, CACNA1C, and EGR1. In addition, the selected molecular markers in the multigenic gene expression classifier were subsequently validated using reverse transcriptase-real time PCR, and an independently acquired gene expression microarray dataset was downloaded from Gene Expression Omnibus. The multigenetic classifier derived herein did similarly or better than standard abdominal ultrasonography and serum α-fetoprotein, which are currently used for hepatocellular carcinoma surveillance. Because early hepatocellular carcinoma diagnosis increases survival by increasing access to therapeutic options, these molecular markers may prove useful for early diagnosis of hepatocellular carcinoma, especially if prospectively validated and translated into gene products that can be reproducibly and reliably tested noninvasively. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2929–32)Other Versions
This publication has 25 references indexed in Scilit:
- ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cellsMolecular Cancer Therapeutics, 2008
- AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver diseaseBMC Cancer, 2008
- Surveillance for Hepatocellular Carcinoma in Patients with Cirrhosis Improves OutcomeThe American Journal of Medicine, 2008
- Supervised group Lasso with applications to microarray data analysisBMC Bioinformatics, 2007
- Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating neviLaboratory Investigation, 2006
- Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approachOncogene, 2005
- Development and validation of therapeutically relevant multi-gene biomarker classifiers.JNCI Journal of the National Cancer Institute, 2005
- matchprobes: a Bioconductor package for the sequence-matching of microarray probe elementsBioinformatics, 2004
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patientsCancer, 1989